Condition (MeSH)
Keratosis, Seborrheic
ClinicalTrials.gov lists 28 trials for Keratosis, Seborrheic or a narrower condition beneath it. Aclaris Therapeutics, Inc. has the most among industry and government lead sponsors, with 8.
Search trials, drugs, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Trials per phase
28 of the 28 trials are tagged with Keratosis, Seborrheic itself; the rest are tagged with a narrower condition beneath it.
When did Keratosis, Seborrheic trials start? (16)
Shown in this order: most recent first, 1990 onwards. 2026 is partial: trials registered with a 2026 start date so far, not a full year.
Trials over time, by phase
- Phase 1/2
- Phase 2
- Phase 3
- Phase 4
- Not applicable
- Observational
Top of scale: 3
Trials registered with a start date in each year, 1990 onward, stacked by phase (complete years only; the current partial year is in the table's notes). The table below lists the same counts, most recent years first.
| Year | Trials started |
|---|---|
| 2026 (partial year) | 1 |
| 2025 | 3 |
| 2024 | 2 |
| 2023 | 2 |
| 2022 | 1 |
| 2021 | 2 |
| 2019 | 3 |
| 2018 | 1 |
| 2017 | 2 |
| 2016 | 3 |
Showing 10 of 16 earlier years.
No forecast is made for this condition: it averages 1.8 trial starts a year over the five years to September, under the 5 a year the method needs.
Recruitment duration, a model prediction: 1 trial still running at the 2026-10-09 snapshot, fewer than the 5 needed for a median. Source: ClinicalTrials.gov / AACT (CTTI), public domain.
What phase are Keratosis, Seborrheic trials in? (6)
Shown in this order: phase order.
Show the trials by phase as a table
| Phase | Trials |
|---|---|
| Phase 1/2 | 1 |
| Phase 2 | 6 |
| Phase 3 | 3 |
| Phase 4 | 1 |
| Not applicable | 9 |
| Observational | 8 |
How many Keratosis, Seborrheic trials are recruiting? (5)
Shown in this order: the order a trial moves through, from not yet recruiting to unknown.
| Status | Trials |
|---|---|
| Not yet recruiting | 1 |
| Completed | 22 |
| Terminated | 2 |
| Withdrawn | 1 |
| Unknown status | 2 |
Status as registered on ClinicalTrials.gov. Each trial is counted once.
Which lead sponsors run the most Keratosis, Seborrheic trials? (5)
Shown in this order: most trials first. Lead sponsors the registry classes as industry, NIH, US federal, other government or network. A hospital or university the registry files as government can appear here. Sponsors it classes as academic or other are shown on the full page, because that class cannot separate an institution from a named investigator.
| Sponsor | Trials |
|---|---|
| Aclaris Therapeutics, Inc. | 8 |
| AI Labs Group S.L | 2 |
| DermBiont, Inc. | 2 |
| Pulse Biosciences, Inc. | 2 |
| Peplin | 1 |
Which drugs are being tested for Keratosis, Seborrheic? (2)
Shown in this order: most trials first. One row per drug, matched to a single molecule under all its names, ranked by number of trials.
| Drug | Trials |
|---|---|
| Hydrogen Peroxide | 2 |
| Petrolatum Ointment | 1 |
Interventions as named in the registry (13)
Shown in this order: most trials first.
| Drug | Trials |
|---|---|
| A-101 Solution | 3 |
| A-101 (32.5) Topical Solution | 2 |
| Vehicle Solution | 2 |
| Curettage | 2 |
| A-101 Vehicle | 2 |
Showing 5 of 13 interventions.
These are the names sponsors entered on ClinicalTrials.gov that we have not matched to a single molecule. Some are drugs under a brand or code name; others are procedures, doses or arm labels.
Which serious adverse events do Keratosis, Seborrheic trials report? (10)
Shown in this order: most subjects affected first. Subjects affected summed across trials, a cross-trial signal, not a rate.
| Adverse event | Subjects affected | Trials |
|---|---|---|
| Acute Pyelonephritis | 4 | 1 |
| Atrial Fibrillation | 2 | 2 |
| Osteoarthritis | 2 | 1 |
| Acute myocardial infarction | 1 | 1 |
| Angina Pectoris | 1 | 1 |
Showing 5 of 10 adverse events.
Which publications cover Keratosis, Seborrheic? (17)
Shown in this order: major-topic papers first, then newest, then most linked to trials.
| Publication | Journal | Year | Major topic |
|---|---|---|---|
| Facial skin characteristics and concerns in Indonesia: A cross-sectional observational study. | Skin research and technology : official journal of International Society for Bioengineering and the Skin (ISBS) [and] International Society for Digital Imaging of Skin (ISDIS) [and] International Society for Skin Imaging (ISSI) | 2022 | Yes |
| Safety and Efficacy of Nanosecond Pulsed Electric Field Treatment of Seborrheic Keratoses. | Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.] | 2020 | Yes |
| Development of a Pigmented Facial Lesion Scale Based on Darkness and Extent of Lesions in Older Veterans. | The Journal of investigative dermatology | 2019 | Yes |
| Anatomic Site-Specific Treatment Response With 40% Hydrogen Peroxide (w/w) Topical Formulation for Raised Seborrheic Keratoses: Pooled Analysis of Data from Two Phase 3 Studies. | Journal of drugs in dermatology : JDD | 2018 | Yes |
| First Safety and Performance Evaluation of T45K, a Self-Assembling Peptide Barrier Hemostatic Device, After Skin Lesion Excision. | Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.] | 2018 | Yes |
Showing 5 of 17 publications.
Not on this page
Not measured: delivery record.
Checked, with nothing recorded for this condition: prevalence, rare-disease identity, and sub-conditions in mesh.